NERV vs ROL · P/E 2.2, $12.4M cap vs P/E 41, rev $1.99B
Minerva Neurosciences Inc (NERV) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
NERV does not have a complete income-statement cache yet.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
NERV currently screens at market cap $12.4M and trailing P/E 2.2. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the NERV and ROL stock pages for the full models.
Not investment advice.